title: Dialysate calcium reduction in CAPD patients treated with CaCO3 alone or CaCO3 and 1 alpha OH vitamin D3.
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: N
authors.initials: N
authors.lastname: el Elśper
authors.forename: P
authors.initials: P
authors.lastname: Moriniere
mesh_terms: D016723:Bone Remodeling; D002118:Calcium / Q000378:metabolism; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000209:etiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D006887:Hydroxycholecalciferols; D002118:Calcium; C008088:alfacalcidol